HLA-A and posterior cortical atrophy: Specific HLA-A alleles, including, but not restricted to, those described here, i.e., HLA-A*02:01 and HLA-A*24:02, as independent prognostic biomarkers, may change therapeutic and clinical follow-up time scheduling, thus significantly contributing to overcome over-diagnosis and over-treatment of PCa patients.